Melissa B. Davis

ORCID: 0000-0002-6124-6923
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Genomics and Diagnostics
  • Prostate Cancer Treatment and Research
  • BRCA gene mutations in cancer
  • Global Cancer Incidence and Screening
  • Chemokine receptors and signaling
  • Estrogen and related hormone effects
  • Nutrition, Genetics, and Disease
  • RNA modifications and cancer
  • Breast Cancer Treatment Studies
  • Cancer-related gene regulation
  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • Molecular Biology Techniques and Applications
  • Genetics, Bioinformatics, and Biomedical Research
  • Cancer Cells and Metastasis
  • Epigenetics and DNA Methylation
  • Immune cells in cancer
  • Cancer-related molecular mechanisms research
  • Genetic factors in colorectal cancer
  • Cancer Risks and Factors
  • Cancer, Lipids, and Metabolism
  • Advanced Breast Cancer Therapies
  • RNA Research and Splicing
  • Economic and Financial Impacts of Cancer
  • Cancer-related Molecular Pathways

Cornell University
2018-2025

Weill Cornell Medicine
2018-2025

Morehouse School of Medicine
2023-2025

Morehouse College
2025

Georgia Research Alliance
2025

Komfo Anokye Teaching Hospital
2018-2024

Presbyterian Hospital
2018-2024

New York Genome Center
2021-2023

Henry Ford Health System
2018-2022

University of Georgia
2005-2022

Women of sub-Saharan African descent have disproportionately higher incidence triple-negative breast cancer (TNBC) and TNBC-specific mortality across all populations. Population studies show racial differences in TNBC biology, including prevalence basal-like quadruple-negative subtypes Americans (AA). However, previous investigations relied on self-reported race (SRR) primarily U.S. Due to heterogeneous genetic admixture biological consequences social determinants, the true association...

10.1158/2159-8290.cd-22-0138 article EN cc-by-nc-nd Cancer Discovery 2022-09-19

Abstract Precision medicine approaches to cancer treatment aim exploit genomic alterations that are specific individual patients tailor therapeutic strategies. Yet, some targetable genes and pathways essential for tumor cell viability even in the absence of direct alterations. In underrepresented populations, mutational landscape determinants response existing therapies poorly characterized because limited inclusion clinical trials studies. One way reveal is with genetic screens. Most...

10.1158/0008-5472.can-24-0775 article EN Cancer Research 2025-02-01

To investigate subtype-specific risk of germline alleles associated with triple negative breast cancer (TNBC) in African ancestry populations.Breast (BC) mortality is higher American (AA) compared to White (WA) women; this disparity partly explained by 2-fold TNBC incidence.We used a surgically maintained biospecimen cohort 2884 BC cases. Subsets the total (760 AA; 962 WA; 910 West African/Ghanaian; 252 East African/Ethiopian) were analyzed for genotypes candidate alleles. A subset 417...

10.1097/sla.0000000000003459 article EN Annals of Surgery 2019-07-29

Abstract Crocin, a component of saffron spice, is known to have an anticancer activity. However, the targets crocin are not known. In this study, was found inhibit proliferation HCC70, HCC1806, HeLa and CCD1059sk cells by targeting microtubules. Crocin depolymerized both interphase mitotic microtubules different cancer cells, inhibited mitosis induced multipolar spindle formation in these cells. vitro , assembly pure tubulin as well microtubule-associated protein rich tubulin. Electron...

10.1038/srep44984 article EN cc-by Scientific Reports 2017-03-24

A size-based ferrohydrodynamic cell separation (FCS) device capable of enriching intact circulating tumor cells with high throughput and recovery rate.

10.1039/c7lc00680b article EN Lab on a Chip 2017-01-01

There is increasing evidence that Androgen Receptor (AR) expression has prognostic usefulness in Triple negative breast cancer (TNBC), where tumors lack AR are considered "Quadruple negative" Breast Cancers ("QNBC"). However, a comprehensive analysis of within all subtypes or stratified by race not been reported. We assessed mRNA 925 from The Cancer Genome Atlas (TCGA), and 136 2 confirmation sets. protein was determined immunohistochemistry 197 multi-institutional cohort, for total 1258...

10.1371/journal.pone.0196909 article EN cc-by PLoS ONE 2018-06-18

Abstract Background: Tumor-specific immune response is an important aspect of disease prognosis and ultimately impacts treatment decisions for innovative immunotherapies. The atypical chemokine receptor 1 (ACKR1 or DARC) gene plays a pivotal role in regulation harbors several single-nucleotide variants (SNV) that are specific to sub-Saharan African ancestry. Methods: Using computational Cancer Genome Atlas (TCGA) analysis, case–control clinical cohort Luminex assays, CIBERSORT deconvolution,...

10.1158/1055-9965.epi-18-0955 article EN Cancer Epidemiology Biomarkers & Prevention 2019-04-01

Poly (ADP-ribose) polymerase inhibitors (PARPi) are used for patients with BRCA1/2 mutations, but other mutations may benefit from PARPi treatment. Another mutation that is present in more cancers than to the TP53 gene. In 2D breast cancer cell lines, mutant p53 (mtp53) proteins tightly associate replicating DNA and (PARP) protein. Combination drug treatment alkylating agent temozolomide talazoparib kills mtp53 expressing grown lines. We evaluated sensitivity combination of plus lung...

10.1016/j.canlet.2024.216608 article EN cc-by Cancer Letters 2024-01-08

miRNA expression in African American compared to Caucasian PCa patients has not been widely explored. Herein, we probed the profile of novel AA and CA derived prostate cancer cell lines. We found a unique signature associated with lines, independent tumor status. Evaluation most differentially expressed miRNAs showed that miR-132, miR-367b, miR-410, miR-152 were decreased more aggressive cells, this was reversed after treatment cells 5-aza-2'-deoxycytidine. Sequencing promoter confirmed it...

10.18632/oncotarget.1953 article EN Oncotarget 2014-05-08

Integrated ferrohydrodynamic cell separation (iFCS) explores magnetization in biocompatible ferrofluids and enriches CTCs an antigen-independent size variation-inclusive manner.

10.1039/c9lc00210c article EN Lab on a Chip 2019-01-01

African American (AA) prostate cancer associates with vitamin D3 deficiency, but D receptor (VDR) genomic actions have not been investigated in this context. We undertook VDR proteogenomic analyses European (EA) and AA cell lines four clinical cohorts. Rapid immunoprecipitation mass spectrometry of endogenous protein (RIME) revealed that nonmalignant RC43N cells displayed the greatest dynamic content complex. Likewise, cells, Assay for Transposase-Accessible Chromatin using sequencing...

10.1158/2767-9764.crc-22-0389 article EN cc-by Cancer Research Communications 2023-04-18

Abstract Background Insulin feedback is a critical mechanism responsible for the poor clinical efficacy of phosphatidylinositol 3-kinase (PI3K) inhibition in cancer, and hyperglycemia an independent factor associated with prognosis glioblastoma (GBM). We investigated combination anti-hyperglycemic therapy mouse model GBM evaluated association glycemic control trial data from patients GBM. Methods The effect regimens, metformin ketogenic diet, was PI3K patient-derived cells orthotopic model....

10.1093/neuonc/noad117 article EN public-domain Neuro-Oncology 2023-06-30

African American Men are 65% more likely to develop prostate cancer and twice as die of cancer, than Caucasian Males. The explanation for this glaring health disparity is still unknown; although a number different plausible factors have been offered including genetic susceptibility gene-environment interactions. We favor the hypothesis that altered gene expression plays major role in observed incidence mortality between To discover genes or pattern(s) unique Males explain males, we conducted...

10.1186/1750-9378-4-s1-s3 article EN cc-by Infectious Agents and Cancer 2009-02-01

// Honghe Wang 1 , Wei Liu 2 ShaNekkia Black Omari Turner Juliet M. Daniel 5 Windy Dean-Colomb 6 Qinghua P. He 3 Melissa Davis 4 Clayton Yates Department of Biology and Center for Cancer Research, Tuskegee University, Tuskegee, AL, USA Laboratory Comparative Carcinogenesis, Frederick, MD, Chemical Engineering, Genetics, University Georgia, Athens, GA, Biology, McMaster Hamilton, ON, Canada Oncologic Hospital Clinics, Lafayette General Health, Lafayette, LA, Correspondence to: Yates, e-mail:...

10.18632/oncotarget.6801 article EN Oncotarget 2015-12-30

More than 40% of patients with luminal breast cancer treated endocrine therapy agent tamoxifen demonstrate resistance. Emerging evidence suggests tumor initiating cells (TICs) and aberrant activation Src Akt signaling drive resistance relapse. We previously demonstrated that aryl hydrocarbon receptor ligand aminoflavone (AF) inhibits the expression TIC gene α6‐integrin disrupts mammospheres derived from tamoxifen‐sensitive cells. In current study, we hypothesize tamoxifen‐resistant (TamR)...

10.1002/jcp.27013 article EN Journal of Cellular Physiology 2018-08-04

BackgroundLow-density neutrophils (LDN) are increased in several inflammatory diseases and may also play a role the low-grade chronic inflammation associated with obesity. Here we explored their obesity, determined gene signatures, assessed effect of bariatric surgery.MethodsWe compared number, function, expression profiles circulating LDN morbidly obese patients (MOP, n=27; body mass index (BMI) > 40 Kg/m2) normal-weight controls (NWC, n=20; BMI < 25 case-control study. Additionally,...

10.1016/j.ebiom.2022.103910 article EN cc-by-nc-nd EBioMedicine 2022-03-01

In this study, we used whole-exome sequencing of a cohort 45 advanced-stage, treatment-naïve Nigerian (NG) primary prostate cancer tumors and 11 unmatched nontumor tissues to compare genomic mutations with African American (AA) European (EA) The Cancer Genome Atlas (TCGA) cancer. NG samples were collected from six sites in central southwest Nigeria. After sequencing, processed using GATK best practices. BRCA1 (100%), BARD1 (45%), BRCA2 (27%), PMS2(18%) had germline alterations at least two...

10.1158/2767-9764.crc-22-0136 article EN cc-by Cancer Research Communications 2022-09-16

Prostate cancer (PCa) is a leading cause of cancer-related deaths and driven by aberrant androgen receptor (AR) signalling. For this reason, deprivation therapies (ADTs) that suppress androgen-induced PCa progression either preventing biosynthesis or via AR signalling inhibition (ARSi) are common treatments. The N6-methyladenosine (m6A) RNA modification involved in regulating mRNA expression, translation, alternative splicing, through these mechanisms has been implicated development...

10.3390/cancers14205148 article EN Cancers 2022-10-20
Coming Soon ...